The post Galaxy Digital Closes $75 Million Tokenized CLO on Avalanche appeared on BitcoinEthereumNews.com. Galaxy Digital has closed its first tokenized collateralizedThe post Galaxy Digital Closes $75 Million Tokenized CLO on Avalanche appeared on BitcoinEthereumNews.com. Galaxy Digital has closed its first tokenized collateralized

Galaxy Digital Closes $75 Million Tokenized CLO on Avalanche

Galaxy Digital has closed its first tokenized collateralized loan obligation (CLO), bringing private credit onto blockchain infrastructure.

The deal, known as Galaxy CLO 2025-1, was issued on Avalanche and has financed roughly $75 million in loans so far, according to a Thursday announcement. The transaction is anchored by a $50 million allocation from Grove, an institutional credit protocol within the Sky ecosystem, formerly known as MakerDAO.

“By uniting our strengths in debt capital markets, blockchain technology, and asset management, we’re opening a new avenue for institutional engagement in credit markets—one that benefits from greater efficiency, transparency, and expanded collateral flexibility through onchain execution,” Chris Ferraro, president and chief investment officer at Galaxy, said.

Galaxy said the CLO is designed to support its lending operations through an uncommitted credit facility extended to Arch Lending, a crypto lending platform backed by Galaxy Ventures. Arch issues consumer loans that are overcollateralized with Bitcoin (BTC) and Ether (ETH). Money from the CLO is used to buy these loans as they are created, with the program able to grow to $200 million over time.

The CLO is issued on Avalanche. Source: Avalanche

Related: Sygnum sees tokenization and state Bitcoin reserves taking off in 2026

Galaxy’s tokenized CLO to trade on INX platform

Crypto trading platform INX issued the CLO’s bonds and put them on the blockchain. The tokens are expected to be listed on INX’s platform for approved investors. The safest portion of the CLO pays interest at a rate tied to the Secured Overnight Financing Rate, or SOFR, plus 5.7%, matures in December 2026 and makes monthly payments, per the announcement.

Galaxy’s internal teams handled the structuring and blockchain setup, while Galaxy Asset Management oversees the product.

Anchorage Digital Bank acts as trustee and custodian, tracking collateral and settlements in real time using its blockchain infrastructure. Galaxy also partnered with Accountable, a data platform that lets investors continuously monitor loan performance and collateral backing the CLO.

Related: LSEG brings commercial bank money onto blockchain rails with DiSH

Stablecoins to overtake ACH payments in 2026: Galaxy

In a recent report, Galaxy Research, the research arm of Galaxy Digital, predicted that stablecoins could handle more transaction volume than the US Automated Clearing House system as early as 2026. The firm noted that stablecoins already process more transactions than major card networks like Visa and now account for roughly half of ACH transaction volume.

Galaxy said stablecoin supply has been growing at a 30%–40% annual rate, with transaction activity rising alongside issuance.

Magazine: How crypto laws changed in 2025 — and how they’ll change in 2026

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/galaxy-digital-closes-75m-tokenized-clo-on-avalanche?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
Yei Finance Logo
Yei Finance Price(CLO)
$0.64026
$0.64026$0.64026
-11.93%
USD
Yei Finance (CLO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26